European farm trials for drug found to prevent laminitis in at-risk horses

Field trials are under way in Europe for a drug which was found to prevent laminitis developing in at-risk ponies in an Australian study.

“This is great news for horse and pony owners because until now we have not had a veterinary drug to prevent or treat laminitis, which affects up to 20 per cent of ponies,” said Professor Martin Sillence, from the Queensland University of Technology in Australia.

The drug called velagliflozin is related to one used to treat human metabolic syndrome.

Click here to read article as seen on the horsetalk.co.nz website